Supernus Pharmaceuticals, Inc. (SUPN)

Trade SUPN now with
9/14/2020 8:26:50 AM Supernus Submits NDA To FDA For Its Apomorphine Infusion Pump SPN-830
12/6/2018 7:07:36 AM Supernus Announces Positive Results From Two Phase III Studies For SPN-812 In Children With ADHD
9/13/2018 4:18:20 PM Supernus To Acquire Biscayne Neurotherapeutics
9/6/2018 3:36:17 PM Supernus Wins Appeal On Oxtellar XR Against TWi
6/27/2018 4:34:27 PM Supernus Pharmaceuticals Elects Carrolee Barlow To Board Of Directors
5/8/2018 4:50:58 PM Supernus Pharmaceuticals Q1 EPS $0.49 Vs. $0.19 Year Ago
3/15/2018 6:55:56 AM Supernus Announces Pricing Of $350 Mln Private Offering Of 0.625% Convertible Senior Notes
11/11/2014 5:32:53 PM Supernus Pharmaceuticals, Inc. (SUPN) Has Raised Its FY14 Revenue Estimate To $115 - $118 Mln From $105 Mln